Hongmin Liu - Search Results

Year	Number of Results
2002	2
2003	3
2004	4
2005	10
2006	10
2007	8
2008	3
2009	10
2010	11
2011	16
2012	10
2013	30
2014	26
2015	19
2016	30
2017	30
2018	37
2019	45
2020	52
2021	55
2022	43
2023	44
2024	14

1

A comprehensive review of SHP2 and its role in cancer.

Asmamaw MD, Shi XJ, Zhang LR, Liu HM. Asmamaw MD, et al. Cell Oncol (Dordr). 2022 Oct;45(5):729-753. doi: 10.1007/s13402-022-00698-1. Epub 2022 Sep 6. Cell Oncol (Dordr). 2022. PMID: 36066752 Review.

2

LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.

Shen DD, Pang JR, Bi YP, Zhao LF, Li YR, Zhao LJ, Gao Y, Wang B, Wang N, Wei L, Guo H, Liu HM, Zheng YC. Shen DD, et al. Mol Cancer. 2022 Mar 16;21(1):75. doi: 10.1186/s12943-022-01557-1. Mol Cancer. 2022. PMID: 35296335 Free PMC article.

3

Skp2 in the ubiquitin-proteasome system: A comprehensive review.

Asmamaw MD, Liu Y, Zheng YC, Shi XJ, Liu HM. Asmamaw MD, et al. Med Res Rev. 2020 Sep;40(5):1920-1949. doi: 10.1002/med.21675. Epub 2020 May 11. Med Res Rev. 2020. PMID: 32391596 Review.

4

Annual review of KRAS inhibitors in 2022.

Wang H, Chi L, Yu F, Dai H, Gao C, Si X, Wang Z, Liu L, Zheng J, Shan L, Liu H, Zhang Q. Wang H, et al. Among authors: liu h. Eur J Med Chem. 2023 Mar 5;249:115124. doi: 10.1016/j.ejmech.2023.115124. Epub 2023 Jan 16. Eur J Med Chem. 2023. PMID: 36680986 Review.

5

Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.

Huo JL, Jiao L, An Q, Chen X, Qi Y, Wei B, Zheng Y, Shi X, Gao E, Liu HM, Chen D, Wang C, Zhao W. Huo JL, et al. Circ Res. 2021 Jul 23;129(3):400-413. doi: 10.1161/CIRCRESAHA.120.318149. Epub 2021 Jun 3. Circ Res. 2021. PMID: 34078090

6

A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer.

Xu T, Ma Q, Li Y, Yu Q, Pan P, Zheng Y, Li Z, Xiong X, Hou T, Yu B, Liu H, Sun Y. Xu T, et al. Among authors: liu h. Signal Transduct Target Ther. 2022 Oct 17;7(1):354. doi: 10.1038/s41392-022-01182-w. Signal Transduct Target Ther. 2022. PMID: 36253371 Free PMC article.

7

Detailed resume of RNA m⁶A demethylases.

Shen D, Wang B, Gao Y, Zhao L, Bi Y, Zhang J, Wang N, Kang H, Pang J, Liu Y, Pang L, Chen ZS, Zheng YC, Liu HM. Shen D, et al. Acta Pharm Sin B. 2022 May;12(5):2193-2205. doi: 10.1016/j.apsb.2022.01.003. Epub 2022 Jan 11. Acta Pharm Sin B. 2022. PMID: 35646549 Free PMC article. Review.

8

Detailed curriculum vitae of HER2-targeted therapy.

Zhang XN, Gao Y, Zhang XY, Guo NJ, Hou WQ, Wang SW, Zheng YC, Wang N, Liu HM, Wang B. Zhang XN, et al. Pharmacol Ther. 2023 May;245:108417. doi: 10.1016/j.pharmthera.2023.108417. Epub 2023 Apr 17. Pharmacol Ther. 2023. PMID: 37075933 Review.

9

Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing.

Wang Z, Kang W, Li O, Qi F, Wang J, You Y, He P, Suo Z, Zheng Y, Liu HM. Wang Z, et al. Acta Pharm Sin B. 2021 Mar;11(3):694-707. doi: 10.1016/j.apsb.2020.11.005. Epub 2020 Nov 16. Acta Pharm Sin B. 2021. PMID: 33777676 Free PMC article.

10

4-Cyclo-propyl-1-(6'-de-oxy-1',2'-O-iso-propyl-idene-α-d-gluco-furanos-yl)-1H-1,2,3-triazole.

Zhang Q, He P, Zhou G, Yu K, Liu H. Zhang Q, et al. Among authors: liu h. Acta Crystallogr Sect E Struct Rep Online. 2013 Aug 7;69(Pt 9):o1386. doi: 10.1107/S1600536813021351. eCollection 2013. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 24427028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

440 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Results by year